Info@ThinkPinkRocks.com

FDA approves Actavis ANDA for guaifenesin/pseudoephedrine tablets to relieve chest congestion

Actavis plc and its partner Perrigo Company plc announced today that Actavis has received U.S. Food and Drug Administration approval for its Abbreviated New Drug Application for guaifenesin/pseudoephedrine tablets and that Perrigo will begin shipments in time for the cough/cold season to its retail and wholesale customers in the U.S

More:
FDA approves Actavis ANDA for guaifenesin/pseudoephedrine tablets to relieve chest congestion

Share

Leave a Reply